Phenoxy aromatic acid with cyclopropyl and pharmaceutically acceptable salt thereof as well as preparation method and application thereof

A phenoxyaromatic acid and pharmacy technology, applied in the field of medicine, can solve problems such as insufficient medicinal effect, and achieve the effects of improving stability and improving medicinal effect

Pending Publication Date: 2021-07-16
HC SYNTHETIC PHARMA CO LTD
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] Although Trilipix solves the water solubility problem to a certain extent, its drug effect is still not strong enough

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Phenoxy aromatic acid with cyclopropyl and pharmaceutically acceptable salt thereof as well as preparation method and application thereof
  • Phenoxy aromatic acid with cyclopropyl and pharmaceutically acceptable salt thereof as well as preparation method and application thereof
  • Phenoxy aromatic acid with cyclopropyl and pharmaceutically acceptable salt thereof as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0050] The preparation of comparative example fenofibric acid and choline salt thereof

[0051] (1) Preparation of fenofibric acid

[0052] Add 72.0 g of fenofibrate and 360 ml of absolute ethanol into a 500 ml reaction bottle, stir and mix. Raise the temperature to 60°C, heat and stir until the solid dissolves into a colorless transparent solution, add 57.6g of 25% sodium hydroxide solution dropwise, and keep the temperature at about 60°C during the dropwise addition. End; the temperature of the reaction solution is lowered to 0-5°C, add concentrated hydrochloric acid dropwise to adjust the pH value of the reaction solution to 2-3, after the drop is complete, stir at 0-5°C for 30 minutes, filter, wash the filter cake with pure water until neutral, and drain , and dried at 65°C to obtain 60.1 g of fenofibric acid.

[0053] (2) Preparation of choline fenofibric acid

[0054] Dissolve 10.0 g of fenofibric acid in 100 ml of isopropanol and heat to 65°C. The choline hydroxide / ...

Embodiment 1

[0055] The preparation of embodiment 1 cyprofenofibric acid

[0056]

[0057] Add 11.2g of anhydrous aluminum trichloride, 42.4ml of toluene, and 7.9ml of anisole into the three-neck flask, stir, control the temperature below 40°C, and slowly add 7.36ml of 4-chlorobenzoyl chloride dropwise. After the dropwise addition, The oil bath was slowly heated to reflux, and reacted for 2 hours. The reaction was tracked by TLC. After the reaction was complete, it was cooled to room temperature, and 50 ml of water was slowly added dropwise under stirring. At this time, a large amount of solids were precipitated, filtered with suction, and the filter cake was washed with an appropriate amount of water. The resulting solids were recrystallized with ethanol to obtain 10.8 g of compound (II).

[0058]

[0059] Add 8.0g of the compound (II) prepared in the previous step, 0.6g of sodium hydroxide, and 96ml of butanone into the three-neck flask, heat up to 45-60°C with stirring, stir for 3...

Embodiment 2

[0061] The preparation of embodiment 2 cycloprofen norofibric acid choline salt

[0062]

[0063] Add 7.5g of ciprofenofibric acid, 75ml of isopropanol, and 6.26g of choline hydroxide solution (45wt%) into the reaction flask. It was heated to 65°C and stirred for 1 hour, then naturally cooled to room temperature, and a solid precipitated out. The solid was collected and dried to give 6.88 g of ciprofen norficate choline salt. m / z: 418.14 (100.0%), 420.14 (32.0%), 419.15 (24.3%), 421.14 (7.8%), 420.15 (3.8%); Elemental Analysis: C, 63.08; H, 6.02; Cl, ​​8.46; N , 3.34; O, 19.10.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention provides phenoxy aromatic acid with cyclopropyl, a preparation method of the phenoxy aromatic acid, pharmaceutically acceptable salt of the phenoxy aromatic acid with cyclopropyl and a preparation method of the pharmaceutically acceptable salt, and further provides dosage forms of the phenoxy aromatic acid with cyclopropyl and the pharmaceutically acceptable salt of the phenoxy aromatic acid with cyclopropyl. The invention also discloses application of the compound in medicines for treating hyperlipidemia diseases. The compound provided by the invention has a relatively good blood fat reducing drug effect, so that the compound has a very good application prospect.

Description

technical field [0001] The invention relates to the technical field of medicine, and more specifically relates to cyclopropyl-containing phenoxyaromatic acid hypolipidemic compounds, pharmaceutically acceptable salts thereof, and their preparation methods and applications. Background technique [0002] Cardiovascular disease is one of the most common and serious diseases that endanger human health (especially middle-aged and elderly people). Dyslipidemia is an important risk factor for atherosclerosis, coronary heart disease and other cardiovascular and cerebrovascular diseases. Lipid-lowering drugs can reduce these The incidence and mortality of diseases have a positive and far-reaching impact on the prevention and treatment of cardiovascular diseases. Statistics from IMSHealth in the United States show that in 2008, the global lipid-lowering drug market reached US$33.849 billion, an increase of 1.75% over the previous year, accounting for 4.38% of the global pharmaceutical...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityApplications(China)
IPC IPC(8): C07C62/38C07C51/367C07C215/08A61K31/192A61P3/06
CPCC07C62/38C07C215/08A61P3/06C07C2601/02C07B2200/13
Inventor陆华龙戚苏民
OwnerHC SYNTHETIC PHARMA CO LTD